Cardiff Oncology shares plunge after Q2 earnings miss
Investing.com - OPTIMIZERx reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
OPTIMIZERx announced earnings per share of $0.07 on revenue of $15.1M. Analysts polled by Investing.com EPS of $0.04 on revenue of $14.86M.
OPTIMIZERx 's are down 35% and is trading at $13.80 , still down 85.09% from its 52 week high of $97.36 set on Monday, November 8, 2021.
OPTIMIZERx shares lost 4.96% to trade at $13.80 in after-hours trade the report.
OPTIMIZERx follows other major Healthcare sector earnings this month
OPTIMIZERx's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar